The Impact of Fibrinogen to Prognostic Nutritional Index Rate on Prognosis of Pancreatic Ductal Adenocarcinoma

被引:2
|
作者
Igarashi, Yosuke [1 ]
Shirai, Yoshihiro [1 ,2 ]
Tanji, Yoshiaki [1 ]
Hamura, Ryoga [1 ]
Yanagaki, Mitsuru [1 ]
Abe, Kyohei [1 ]
Onda, Shinji [1 ]
Furukawa, Kenei [1 ]
Matsumoto, Michinori [1 ]
Tsunematsu, Masashi [1 ]
Ikegami, Toru [1 ]
机构
[1] Jikei Univ, Sch Med, Dept Surg, Div Hepatobiliary & Pancreas Surg, Tokyo, Japan
[2] Jikei Univ, Sch Med, 3-25-8 Nishi Shinbashi, Minato Ku, Tokyo 1058461, Japan
基金
日本学术振兴会;
关键词
pancreatic cancer; prognostic nutritional index; fibrinogen; tumor microenvironment; prognosis; PREOPERATIVE PLATELET; CANCER; LYMPHOCYTE;
D O I
10.1177/00031348231204912
中图分类号
R61 [外科手术学];
学科分类号
摘要
Introduction: The aim of the present study was to evaluate the prognostic value of the ratio of serum fibrinogen to prognostic nutritional index (PNI; Fbg/PNI) in patients undergoing resection for pancreatic ductal adenocarcinoma.Methods: A total of 140 patients who had undergone resection for pancreatic cancer were included. Patients were divided into two groups according to a Fbg/PNI >= 8.8 or <8.8. Survival data were analyzed using the log-rank test for univariate analysis and Cox proportional hazards for multivariate analysis.Results: Fbg/PNI was a significant prognostic indicator in univariate analysis for overall survival (OS) and disease-free survival (DFS). Fbg/PNI retained significance in multivariate analysis for OS (hazard ratio, 1.81; 95% confidence interval, 1.19-2.77; P < .01) in addition to tumor differentiation and nodal involvement. Fbg/PNI was a significant independent prognostic indicator of poor DFS on multivariate analysis (hazard ratio, 1.54; 95% confidence interval, 1.05-2.26; P = .03).Conclusion: Preoperative Fbg/PNI is a novel significant independent prognostic indicator for OS and DFS following resection of pancreatic cancer with curative intent.
引用
收藏
页码:4255 / 4261
页数:7
相关论文
共 50 条
  • [21] Spatial determination and prognostic impact of the fibroblast transcriptome in pancreatic ductal adenocarcinoma
    Croft, Wayne
    Pearce, Hayden
    Margielewska-Davies, Sandra
    Lim, Lindsay
    Nicol, Samantha M.
    Zayou, Fouzia
    Blakeway, Daniel
    Marcon, Francesca
    Powell-Brett, Sarah
    Mahon, Brinder
    Merard, Reena
    Zuo, Jianmin
    Middleton, Gary
    Roberts, Keith
    Brown, Rachel M.
    Moss, Paul
    ELIFE, 2023, 12
  • [22] Prognostic impact of carbohydrate sulfotransferase 15 in patients with pancreatic ductal adenocarcinoma
    Ito, Zensho
    Takakura, Kazuki
    Suka, Machi
    Kanai, Tomoya
    Saito, Ryota
    Fujioka, Shuichi
    Kajihara, Mikio
    Yanagisawa, Hiroyuki
    Misawa, Takeyuki
    Akiba, Tadashi
    Koido, Shigeo
    Ohkusa, Toshifumi
    ONCOLOGY LETTERS, 2017, 13 (06) : 4799 - 4805
  • [23] The Activated Stroma Index Is a Novel and Independent Prognostic Marker in Pancreatic Ductal Adenocarcinoma
    Erkan, Mert
    Michalski, Christoph W.
    Rieder, Simon
    Reiser-Erkan, Carolin
    Abiatari, Ivane
    Kolb, Armin
    Giese, Nathalia A.
    Esposito, Irene
    Friess, Helmut
    Kleeff, Joerg
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2008, 6 (10) : 1155 - 1161
  • [24] Prognostic Significance of Plasma Fibrinogen/Serum Albumin Ratio in the Postoperative Outcome of Pancreatic Ductal Adenocarcinoma
    Tomita, Koichi
    Ochiai, Shigeto
    Gunji, Takahiro
    Hikita, Kosuke
    Kobayashi, Toshimichi
    Sano, Toru
    Chiba, Naokazu
    Kawachi, Shigeyuki
    ANTICANCER RESEARCH, 2020, 40 (12) : 7017 - 7023
  • [25] Pancreatic Ductal Adenocarcinoma: Relating Biomechanics and Prognosis
    MacCurtain, Benjamin M.
    Quirke, Ned P.
    Thorpe, Stephen D.
    Gallagher, Tom K.
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (12)
  • [26] A New Stemness-Related Prognostic Model for Predicting the Prognosis in Pancreatic Ductal Adenocarcinoma
    Huang, Xiao-Yan
    Qin, Wen-Tao
    Su, Qi-Sheng
    Qiu, Cheng-Cheng
    Liu, Ruo-Chuan
    Xie, Shan-Shan
    Hu, Yang
    Zhu, Shang-Yong
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [27] Prognostic impact of early nutritional support in patients affected by locally advanced and metastatic pancreatic ductal adenocarcinoma undergoing chemotherapy
    Trestini, Ilaria
    Carbognin, Luisa
    Sperduti, Isabella
    Bonaiuto, Clelia
    Auriemma, Alessandra
    Melisi, Davide
    Salvatore, Lisa
    Bria, Emilio
    Tortora, Giampaolo
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2018, 72 (05) : 772 - 779
  • [28] Prognostic impact of early nutritional support in patients affected by locally advanced and metastatic pancreatic ductal adenocarcinoma undergoing chemotherapy
    Ilaria Trestini
    Luisa Carbognin
    Isabella Sperduti
    Clelia Bonaiuto
    Alessandra Auriemma
    Davide Melisi
    Lisa Salvatore
    Emilio Bria
    Giampaolo Tortora
    European Journal of Clinical Nutrition, 2018, 72 : 772 - 779
  • [29] Impact of intratumoral microbiome on tumor immunity and prognosis in human pancreatic ductal adenocarcinoma
    Abe, Shohei
    Masuda, Atsuhiro
    Matsumoto, Tomonori
    Inoue, Jun
    Toyama, Hirochika
    Sakai, Arata
    Kobayashi, Takashi
    Tanaka, Takeshi
    Tsujimae, Masahiro
    Yamakawa, Kohei
    Gonda, Masanori
    Masuda, Shigeto
    Uemura, Hisahiro
    Kohashi, Shinya
    Inomata, Noriko
    Nagao, Kae
    Harada, Yoshiyuki
    Miki, Mika
    Irie, Yosuke
    Juri, Noriko
    Ko, Testuhisa
    Yokotani, Yusuke
    Oka, Yuki
    Ota, Shogo
    Kanzawa, Maki
    Itoh, Tomoo
    Imai, Toshio
    Fukumoto, Takumi
    Hara, Eiji
    Kodama, Yuzo
    JOURNAL OF GASTROENTEROLOGY, 2024, 59 (03) : 250 - 262
  • [30] Impact of tertiary lymphoid structures on prognosis and therapeutic response in pancreatic ductal adenocarcinoma
    Merali, Nabeel
    Jessel, Maria-Danae
    Arbe-Barnes, Edward H.
    Lee, Wing Yu Ruby
    Gismondi, Martha
    Chouari, Tarak
    O'Brien, James W.
    Patel, Bhavik
    Osei-Bordom, Daniel
    Rockall, Timothy A.
    Sivakumar, Shivan
    Annels, Nicola
    Frampton, Adam E.
    HPB, 2024, 26 (07) : 873 - 894